NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma

TerminatedN/A

Sponsor: AstraZeneca

Conditions: Asthma, Bronchial

Countries: Germany

This is a multi-center, single-country, single-arm, prospective, disease study to collect real world data of patients with severe uncontrolled asthma in Germany.

Eligibility overview

Sex: ALL

Age: 18 Years to 120 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* ≥18 years of age at the time of consent
* Therapy within GINA/NVL steps 4 or 5 and uncontrolled disease in the previous 12 months as per the healthcare provider's assessment
* Willing and able to provide written informed consent indicating that they understand the purpose and procedures required for the study and are willing to participate
* Able to read, understand, and speak German sufficiently to complete all the questionnaires

Exclusion Criteria:

* According to the assessment of the study physician: cognitive impairment, psychiatric diseases, severe hearing or vision impairment, insufficient knowledge of the German language, if these factors could influence the ability to provide written consent and correct completion and assessment of the questionnaires.
* Current participation in an observational study that might, in the investigator's opinion, influence the assessment for the current study, or participation in a randomized clinical trial in the last 30 days.

Locations (6)

Berlin, Germany
Blankenhein, Germany
Bonn, Germany
Fürstenwalde, Germany
Gauting, Germany
Weißenburg, Germany